These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20807647)

  • 1. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
    Foley EM; Esko JD
    Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism.
    Bishop JR; Stanford KI; Esko JD
    Curr Opin Lipidol; 2008 Jun; 19(3):307-13. PubMed ID: 18460924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.
    MacArthur JM; Bishop JR; Stanford KI; Wang L; Bensadoun A; Witztum JL; Esko JD
    J Clin Invest; 2007 Jan; 117(1):153-64. PubMed ID: 17200715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
    Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
    J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
    Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.
    Fischer AW; Albers K; Krott LM; Hoffzimmer B; Heine M; Schmale H; Scheja L; Gordts PLSM; Heeren J
    Mol Metab; 2018 Oct; 16():88-99. PubMed ID: 30100244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.
    Bishop JR; Passos-Bueno MR; Fong L; Stanford KI; Gonzales JC; Yeh E; Young SG; Bensadoun A; Witztum JL; Esko JD; Moulton KS
    PLoS One; 2010 Nov; 5(11):e13919. PubMed ID: 21085708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
    Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
    Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.
    Mahley RW; Huang Y
    J Clin Invest; 2007 Jan; 117(1):94-8. PubMed ID: 17200713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.
    Stanford KI; Wang L; Castagnola J; Song D; Bishop JR; Brown JR; Lawrence R; Bai X; Habuchi H; Tanaka M; Cardoso WV; Kimata K; Esko JD
    J Biol Chem; 2010 Jan; 285(1):286-94. PubMed ID: 19889634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E.
    Newman P; Bonello F; Wierzbicki AS; Lumb P; Savidge GF; Shearer MJ
    J Bone Miner Res; 2002 Mar; 17(3):426-33. PubMed ID: 11874234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.
    Mahley RW; Ji ZS
    J Lipid Res; 1999 Jan; 40(1):1-16. PubMed ID: 9869645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique.
    Lookene A; Savonen R; Olivecrona G
    Biochemistry; 1997 Apr; 36(17):5267-75. PubMed ID: 9136889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.
    Deng Y; Foley EM; Gonzales JC; Gordts PL; Li Y; Esko JD
    Hepatology; 2012 Jan; 55(1):277-86. PubMed ID: 21898481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular metabolism of triglyceride-rich lipoproteins: role of heparan sulfate, lipoprotein lipase and lipoprotein receptors.
    Sehayek E; Eisenberg S
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():110-2. PubMed ID: 8767482
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate.
    Bishop JR; Foley E; Lawrence R; Esko JD
    J Biol Chem; 2010 May; 285(19):14658-62. PubMed ID: 20236939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinuria converts hepatic heparan sulfate to an effective proprotein convertase subtilisin kexin type 9 enzyme binding partner.
    Shrestha P; Yazdani S; Vivès RR; El Masri R; Dam W; van de Sluis B; van den Born J
    Kidney Int; 2021 Jun; 99(6):1369-1381. PubMed ID: 33609572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface heparan sulfate proteoglycans and lipoprotein metabolism.
    Kolset SO; Salmivirta M
    Cell Mol Life Sci; 1999 Nov; 56(9-10):857-70. PubMed ID: 11212344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.